StockWatch
·
Pharmaceuticals
Corporate Action19 Nov 2026, 06:10 pm

Dipna Pharmachem Increases Authorized Capital by ₹3.5 Cr

AI Summary

Dipna Pharmachem Ltd announced board approval for an increase in authorized share capital from ₹28.50 Crores to ₹32.00 Crores, an increase of ₹3.50 Crores. This alteration to the Memorandum of Association is subject to shareholder approval. The board also considered and recommended material related party transactions with Ohara Pharmachem Private Limited, Dipan Pharmachem Private Limited, Cedac Medicorp, Dhara Chemicals, and Dipan Pharma Chern for shareholder approval at the upcoming Annual General Meeting (AGM). The 15th AGM is scheduled for September 30, 2026.

Key Highlights

  • Authorized share capital increased by ₹3.50 Crores.
  • Memorandum of Association alteration requires shareholder approval.
  • Material related party transactions recommended for shareholder approval.
  • 15th AGM scheduled for September 30, 2026.